Unique somatic and malignant expression patterns implicate PIWI-interacting RNAs in cancer-type specific biology

Area of Science:

• Molecular Biology
• Genomics
• Cancer Research

Background:

• Human PIWI-interacting RNAs (piRNAs) are primarily known for germline expression and silencing of repetitive elements.
• The expression patterns and roles of piRNAs in human somatic tissues remain largely uncharacterized.

Purpose of the Study:

• To investigate the expression landscape of piRNAs in human somatic non-malignant and tumor tissues.
• To determine if piRNA expression can serve as a biomarker for tissue-of-origin and cancer type.
• To explore the correlation between piRNA expression and clinical features in cancer patients.

Main Methods:

• Analysis of 6,260 human piRNA transcriptomes from non-malignant and tumor tissues across 11 organs.
• Bioinformatic analysis to identify expressed piRNAs, their mapping locations, and differential expression patterns.
• Statistical analysis to correlate piRNA expression with tissue-of-origin, cancer type, and clinical parameters.

Main Results:

• Only 273 of 20,831 known piRNAs are expressed in somatic non-malignant tissues, with distinct tissue-specific patterns.
• 522 piRNAs are expressed in tumor tissues, differentiating tumor from non-malignant samples in a cancer-type specific manner.
• piRNA expression patterns correlate with histological subgroups, disease stages, and patient survival.

Conclusions:

• Somatic piRNA expression is tissue-specific and can distinguish between non-malignant and tumor tissues.
• piRNAs hold potential as biomarkers for cancer type classification and predicting clinical outcomes.
• Commonly expressed piRNAs across cancers may indicate core cancer growth mechanisms, while unique piRNAs suggest cancer-specific roles.